The Ledger (blog) The newer classes of drugs studied, DPP-IV inhibitors and GLP-1 agonists, were compared with an older drug called sulfonylurea . “Conventional wisdom ...
Drug Discovery & Development The simulation model, developed by lead study author Yuanhui Zhang, a doctoral student at North Carolina State, compared the newer classes known as DPP-IV inhibitors and GLP-1 agonists with the older drug called sulfonylurea . They all have different ...
agprofessional.com Cibus Global, a precision gene editing firm, announced its first commercial product SU Canola ( sulfonylurea tolerant) has received Plant Novel Trait (PNT) approval by the Canadian Food Inspection Agency (CFIA) and Health Canada (HC). With this ...
Virtual Press Office (press release) DUAL™ II, which compared the efficacy and safety of IDegLira versus Tresiba® alone in people with type 2 diabetes, which was uncontrolled on basal insulin (20-40U) + metformin ± sulfonylurea or glinides. LIRA-DETEMIR™, which compared a combination ... and more »
FarmersWeekly Again, the overuse of sulfonylurea herbicides is to blame. In contrast to chickweed, both of the target-site mutations have been found in poppies, meaning that more herbicides are affected and won't work where both mutations exist, including florasulam.
Medscape Use of a sulfonylurea as second-line therapy after metformin for type 2 diabetes is just as effective as a newer agent but far less costly, a new study based on claims data finds. The results were published online February 26 in Diabetes Care by ...
BioNews Texas A recent study indicated that using sulfonylurea after metformin for the treatment of type 2 diabetes has as much of an effect as using other conventional treatments, but costs far less. The study was published online on the 26th of February in the ...
Family Practice News Digital Network BARCELONA – Treatment of type 2 diabetes with a sulfonylurea drug was tied to a significantly increased risk of death in two large U.K. epidemiology studies with a total of more than 100,000 patients. These and other recent findings that raised ... and more »
Zacks.com Merck is working on penetrating the sulfonylurea class. One of the factors adversely impacting revenues could be Increased rebate and pricing pressure as competitors are working on improving their formulary positions by increasing discounts. Gardasil ... and more »
Family Practice News Digital Network BARCELONA – Treatment of type 2 diabetes with a sulfonylurea drug was tied to a significantly increased risk of death in two large U.K. epidemiology studies with a total of more than 100,000 patients. These and other recent findings that raised ... and more »
